All articles by Swagath Bandhakavi

Swagath Bandhakavi

WellRX acquires Bioreach to expand bloodwork and genetic testing capabilities

The acquisition of Bioreach will allow WellRX to internalise its diagnostic capabilities, strengthening its capacity to deliver advanced health tests throughout its ecosystem

PixCell Medical’s HemoScreen CBC Analyzer achieves IVDR certification

By securing IVDR certification years ahead of the regulatory deadline, HemoScreen reaffirms PixCell Medical’s proactive commitment to quality, safety, and innovation

MDVIP expands in Massachusetts with Boston and Cape Cod internal medicine practices

Multi board-certified internists Dr. Nobita Chatterjee in Newton and Dr. Annemarie Armani in Falmouth join MDVIP network to provide membership-based medicine in the Commonwealth

Care Access to offer no-cost heart and kidney health screenings in Chicago

No-cost health screening event in Chicago targets kidney disease, diabetes, and often unknown heart risk that runs in families

University of Kansas Medical Center enhances robotic heart care programme with Genesis robotic technology

The Genesis System is the latest advancement in Robotic Magnetic Navigation technology

AMRA Medical research in muscle and nerve demonstrates utility of MRI-based biomarkers in inflammatory myopathies

The recent study details the use of fat-referenced volumetric muscle composition measurements as reliable biomarkers of disease progression and treatment response in sporadic inclusion body myositis, building upon AMRA’s increasing expertise in the neuromuscular disease space

Capsa Healthcare announces new interface to EMIS ProScript Connect for RoboWall prescription pickup efficiency

RoboWall, part of Capsa Healthcare’s RoboPharma pharmacy automation group, is a fully automated prescription pickup center designed to give pharmacies unparalleled convenience for around-the-clock prescription retrieval

Alpha Tau treats first patient with recurrent lung cancer

The trial is designed to treat up to ten patients with recurrent tumors in the mediastinum area of the chest, and allows for the use of concurrent chemotherapy, targeted therapy, or immunotherapy, if indicated

Avicenna.AI’s CINA-CSpine gets FDA clearance for cervical spine fracture detection

The tool uses advanced AI, including deep learning and machine learning, to rapidly detect and flag potentially life-threatening conditions

BayCare breaks ground on cancer institute expansion to bring revolutionary MEVION S250-FIT Proton Therapy to Tampa

BayCare will be the first to offer this advanced therapy in Tampa, Florida, with the facility expected to be operational by the end of 2025.